David Hollander Revance Therapeutics, Inc. (RVNC) insider trading activity

RVNC Quotes by TradingView

David Hollander is CMO & Global Therapeutics Lead of Revance Therapeutics, Inc.. Currently has a direct ownership of 104,945 shares of RVNC, which is worth approximately $269,708. The most recent transaction as insider was on Nov 18, 2024, when has been sold 3,908 shares (Common Stock) at a price of $4.17 per share, resulting in proceeds of $16,296. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 105K
n/a 3M change
n/a 12M change
Total Value Held $269,708

David Hollander Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 18 2024
SELL
Open market or private sale
$16,296 $4.17 p/Share
3,908 Reduced 3.59%
104,945 Common Stock

Also insider at

AERI
AERIE PHARMACEUTICALS INC Healthcare
Chief R&D Officer
KPRX
KIORA PHARMACEUTICALS INC Healthcare
Director
DH

David Hollander

CMO & Global Therapeutics Lead
Durham, NC

Track Institutional and Insider Activities on RVNC

Follow Revance Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RVNC shares.

Notify only if

Insider Trading

Get notified when an Revance Therapeutics, Inc. insider buys or sells RVNC shares.

Notify only if

News

Receive news related to Revance Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on RVNC